Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)

Clinical trial NCT01822418 · COMPLETED

Trial details

NCT number: NCT01822418
Sponsor: Central Institute of Mental Health, Mannheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Delusional Disorder

Start date: 2013-01-01
Primary completion: 2015-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.